Testing Health Workers At Risk to Advance Our Understanding of TB Infection

Recruiting now

Conditions studied: Tuberculosis, Tuberculosis Infection

In brief

It has been estimated that 1.7 billion people have tuberculosis (TB) infection; yet current tests are unable to predict which people are at highest risk of developing TB disease, which can be life-threatening. THWART-TB is a prospective longitudinal cohort study of health workers (HWs) in Cape Town, South Africa, where our preliminary data reveals HWs have a high annual TB infection risk (34%). This cohort, who will undergo frequent serial evaluation (every 3 months) with a combination of novel assays never previously evaluated together, presents a unique opportunity to evaluate immune responses at the time of initial infection and to characterize the dynamic profile of these immune responses over time in a high-risk population. The knowledge generated will improve our understanding of TB infection and help to identify which people exposed to TB may remain at risk, enabling us to better target preventive strategies.

Key facts

Study ID

NCT06221488

Run by

Beth Israel Deaconess Medical Center

People needed

300

Starts

2024-01-15

Expected to finish

2029-12-31

Last updated by the study team

2026-07-08

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥18 years old
• Health worker
• Able to provide informed consent

You may not qualify if…

• Prior history of TB or known prior positive IGRA
• Current or prior history of taking anti-TB treatment

Where it is running

• Stellenbosch University — Cape Town, South Africa (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.